Buprenorphine withdrawal presents challenges for those seeking to discontinue this medication, whether prescribed for pain management or opioid use disorder treatment. Understanding the withdrawal process is beneficial for anyone considering stopping buprenorphine or supporting a loved one through this transition.
This page examines buprenorphine withdrawal, covering who uses this drug, the prevalence of misuse, withdrawal symptom profiles, expected timelines, and evidence-based treatment approaches that support safe discontinuation.
Who Uses Buprenorphine?
Buprenorphine is a partial opioid agonist medication that binds to opioid receptors in the brain, serving two primary clinical purposes. Physicians prescribe it for moderate to severe pain management when other analgesics prove insufficient [1]. More commonly, buprenorphine treatment is a cornerstone in opioid use disorder treatment programs [2].
The medication comes in several formulations. Subutex contains only buprenorphine, while Suboxone contains both buprenorphine with naloxone to deter misuse. Sublocade offers a monthly injectable option for sustained treatment. Belbuca and Bunavail offer additional delivery methods, while Buprenex is used in hospital settings.
Healthcare providers increasingly prescribe buprenorphine within medication-assisted treatment frameworks. This approach combines pharmacological support with counseling and behavioral therapies to comprehensively treat opioid dependence [3].
How Common Is Buprenorphine Misuse?
Classified as a Schedule III controlled substance, buprenorphine has accepted medical uses but carries potential for abuse. A survey analyzing data from more than 214,000 people who took part in the National Survey on Drug Use and Health [4] showed that almost 3 out of 4 adults who used buprenorphine said they used it as prescribed and did not misuse it. Among adults with opioid use disorder, buprenorphine misuse decreased from 2015 to 2019. When misuse did occur, the most common reasons were feeling dependent on the medication or using it to help manage physical pain.
A review of 17 studies [5] indicates that most people reported using illicit buprenorphine to cope with opioid withdrawal or to stay away from other opioids. Far fewer said they used it to feel high. Overall, these findings point to a clear problem: many people need buprenorphine but cannot easily get it through proper medical treatment. Even though the studies used different methods, they told the same basic story. People most often turned to illicit buprenorphine to relieve withdrawal symptoms when they could not access formal medication-assisted treatment.
Common street names include:
-
Subs.
-
Sobos.
-
Oranges.
-
Strips.
-
Stops.
When combined with central nervous system depressants like benzodiazepines or alcohol, buprenorphine produces enhanced intoxication effects while dramatically increasing overdose risk through respiratory depression.
Effects of Buprenorphine Misuse
Misusing buprenorphine triggers various physiological and psychological effects. People may experience euphoria, especially at higher doses or when the medication is injected rather than taken sublingually. This euphoric response reinforces continued misuse despite adverse outcomes.
Drowsiness and sedation often accompany buprenorphine use, particularly when combined with other sedating substances. Cognitive impairment can manifest as confusion, difficulty concentrating, memory loss, and slowed reaction times, compromising safety during activities such as driving or operating machinery.
Physical symptoms include:
-
Nausea.
-
Vomiting.
-
Constipation.
-
Sweating.
More serious complications involve respiratory depression, especially when buprenorphine is mixed with benzos or alcohol, creating high risk for fatal overdose.
Some people misuse buprenorphine in misguided attempts to self-manage opioid withdrawal symptoms. While buprenorphine effectively treats withdrawal under medical supervision, unsupervised use often leads to inadequate dosing or a return to more potent opioid use.
Buprenorphine Withdrawal Symptoms
Discontinuing buprenorphine triggers a distinct withdrawal syndrome characterized by physical and psychological symptoms.
Withdrawal symptoms from buprenorphine typically include:
-
Muscle aches.
-
Joint pain.
-
Nausea.
-
Vomiting.
-
Diarrhea.
-
Excessive sweating.
-
Runny nose.
-
Watery eyes.
-
Dilated pupils.
-
Elevated heart rate.
-
Insomnia.
-
Fatigue.
Psychological manifestations encompass low mood and depression that’s often severe and persistent, anxiety ranging from mild unease to panic-level intensity, and irritability with rapid mood swings. Intense cravings for buprenorphine or other opioids develop alongside difficulty concentrating and mental fog affecting daily functioning. Anhedonia (the inability to experience pleasure from normally enjoyable activities) frequently emerges [6].
The severity of withdrawal symptoms of buprenorphine varies widely based on multiple factors. Longer duration of use typically correlates with more intense and prolonged withdrawal experiences. Higher doses similarly predict more challenging discontinuation courses. Individual physiological differences, including metabolism, age, and overall health status, influence symptom severity and duration.
Buprenorphine’s long half-life of 38 hours [7] delays withdrawal onset. This leads to a distinctive withdrawal pattern that evolves gradually rather than peaking within days.
For individuals using transdermal delivery systems, buprenorphine patch withdrawal may manifest differently from oral or sublingual formulations because of sustained tissue concentrations even after patch removal.
Buprenorphine Withdrawal Timeline
The buprenorphine withdrawal timeline unfolds in phases, each characterized by distinct symptom patterns. This predictable progression helps individuals and treatment providers anticipate challenges and implement appropriate supportive interventions.
Initial phase (24 to 72 hours)
Early withdrawal from buprenorphine begins subtly, often with restlessness, mild anxiety, and anticipatory discomfort. Pupils may begin to dilate, and some people may notice increased sweating or slight temperature dysregulation. Sleep quality often deteriorates first.
Acute phase (days 2 to 7)
Symptoms intensify during this period, reaching peak severity around days 3 to 5 for most people. Physical discomfort becomes pronounced, with widespread muscle aches, gastrointestinal distress, and autonomic instability. Psychological symptoms escalate, bringing significant mood disturbance, anxiety, and powerful cravings.
Subacute phase (days 8 to 14)
Physical symptoms gradually diminish during the second week, although fatigue and sleep disturbances often persist. Psychological symptoms may remain prominent, particularly depression and anhedonia. Cravings continue but typically become less intense and more manageable with appropriate coping strategies.
Protracted phase (weeks 3+)
Some people experience lingering symptoms extending weeks or months beyond acute withdrawal. This protracted withdrawal syndrome involves primarily psychological manifestations: subtle mood disturbances, intermittent cravings, sleep irregularities, and energy fluctuations.
Individual timelines vary substantially. Factors influencing duration include total time on buprenorphine, dosage history, tapering approach, co-occurring mental health conditions, and overall physical health. Those who taper gradually typically experience milder, more protracted buprenorphine withdrawals than abrupt discontinuation.
Understanding how long withdrawal symptoms last helps set realistic expectations. While acute symptoms typically resolve within 1 to 2 weeks, complete recovery may take several months.
Buprenorphine Addiction Treatment
Comprehensive treatment for buprenorphine dependence addresses both the physical withdrawal process and the underlying factors contributing to substance use. Evidence-based approaches optimize outcomes while minimizing discomfort and the risk of relapse.
Medical detoxification
Medically supervised buprenorphine detox provides the safest approach to managing withdrawal. Doctors use tools like the Clinical Opiate Withdrawal Scale (COWS) to assess symptom severity and intervene promptly if complications arise.
Medical professionals monitor vital signs and offer access to medications that alleviate specific withdrawal symptoms (antiemetics for nausea, sleep aids for insomnia, and anxiolytics for severe anxiety).
For individuals wondering how to wean off buprenorphine, gradual dose reduction is the gold standard approach. Tapering protocols typically decrease doses by 10 to 25% every 1 to 2 weeks, adjusting based on individual tolerance and symptom severity. Slower tapers generally produce less intense withdrawal effects.
Therapeutic interventions
Behavioral therapies are central to sustainable recovery. CBT (cognitive behavioral therapy) helps individuals identify triggers, develop coping strategies, and restructure thought patterns that perpetuate substance use. Group therapy provides peer support, reducing isolation and promoting accountability.
Individual counseling addresses underlying psychological factors contributing to substance dependence. Trauma, mood disorders, anxiety conditions, and chronic stress often coexist with opioid use disorders, requiring targeted therapeutic attention.
Comprehensive treatment planning
Effective programs assess each person’s unique needs and circumstances. Treatment plans integrate multiple therapeutic modalities, such as medical management, psychotherapy, family involvement, and alternative therapies.
For those seeking information on how to detox from buprenorphine, professional guidance is essential. While the internet provides general information, an individualized medical assessment ensures safety and optimizes outcomes. Self-directed detoxification carries significant risks, including severe symptoms and premature return to opioid use.
Continuum of care
Recovery goes far beyond initial detoxification, though. Intensive outpatient programs provide structured support while allowing individuals to maintain work and family commitments. Residential treatment offers immersive therapeutic environments for those requiring more intensive support.
Sober living facilities bridge the gap between formal treatment and independent living. These structured environments enforce sobriety requirements while supporting employment, education, and community reintegration.
Aftercare planning begins during treatment to ensure seamless transitions between care levels. Ongoing counseling, participation in support groups, and medication management provide sustained support as individuals rebuild their lives.
Family involvement
Substance dependence affects entire family systems, making family therapy an invaluable treatment component. Education helps loved ones understand addiction as a medical condition rather than a moral failing.
FAQs
What happens if you suddenly stop buprenorphine?
Abruptly stopping buprenorphine triggers acute withdrawal symptoms, including severe body aches, gastrointestinal distress, anxiety, depression, and intense cravings. The long half-life delays symptom onset but produces a prolonged, uncomfortable withdrawal course lasting several weeks without medical intervention.
What is the timeline for Suboxone withdrawal?
Suboxone withdrawal typically begins 24 to 72 hours after the last dose, peaks during days 3 to 5, and gradually improves over 1 to 2 weeks. That said, psychological symptoms and low energy may persist for several months as the brain recalibrates its natural opioid systems.
How long does withdrawal take from buprenorphine?
Acute buprenorphine withdrawal lasts approximately 1 to 2 weeks for most people, with physical symptoms resolving first. Psychological symptoms, including mood disturbances, sleep problems, and intermittent cravings, may continue for several months during the protracted withdrawal phase.
How long do withdrawal symptoms last?
The duration of withdrawal symptoms varies from person to person, but most experience acute symptoms for 7 to 14 days. Some individuals face protracted symptoms, including depression, anxiety, and fatigue, lasting 2 to 6 months or more, particularly when discontinuing after prolonged use.
What is the 3-day rule for buprenorphine?
The 3-day rule refers to waiting 12 to 24 hours after short-acting opioid use or 24 to 72 hours after long-acting opioids before initiating buprenorphine to prevent precipitated withdrawal. Starting buprenorphine too soon displaces other opioids from receptors, triggering severe and immediate withdrawal symptoms.
Get Evidence-Based Treatment for any Opioid Addiction at a Top-Rated California Rehab
If you are addicted to buprenorphine, reach out to California Detox today for compassionate and effective prescription drug treatment.
Our medical detox program helps reduce the intensity of withdrawal symptoms and cravings while stabilizing you for ongoing treatment. Inpatient therapy at our luxury beachside facility enables you to address the psychological aspect of opioid addiction in a trigger-free, distraction-free environment. You can also tackle any co-occurring mental health issues simultaneously to promote whole-body healing.
All our treatment plans are personalized, with therapies that include:
Kickstart your recovery from opioid addiction today by calling our admissions team at 888-995-4208.
Sources
[1] https://www.sciencedirect.com/science/article/pii/S0885392404005664
[2] https://pmc.ncbi.nlm.nih.gov/articles/PMC6585403/
[3] https://pmc.ncbi.nlm.nih.gov/articles/PMC7278292/
[4] https://pmc.ncbi.nlm.nih.gov/articles/PMC8520126
[5] https://www.sciencedirect.com/science/article/pii/S0740547218304720
[6] https://www.sciencedirect.com/topics/medicine-and-dentistry/anhedonia
[7] https://www.ncbi.nlm.nih.gov/books/NBK459126/
